The authors developed a “covid-19 impact index” based on two measures associated with increases in the prevalence of depressive and anxiety disorders: reductions in mobility and the daily covid-19 infection rate.
The authors then used this index to estimate the change in prevalence of depressive and anxiety disorders across 204 countries and territories.
Of the additional 53m cases of depression and 76m cases of anxiety estimated for 2020, roughly two-thirds were in women.
According to the authors’ estimates, cases of depression increased by 37% in North Africa and the Middle East, more than any other region.